76 research outputs found

    Influence of low doses of gamma irradiation on cowpea beetle Callosobruchus maculatus (F.) (Coleoptera: Chrysomelidae): Poster

    Get PDF
    Phytosanitary irradiation for food commodities has been widely accepted in recent years. Gamma irradiation has been used as a phytosanitary treatment against microbial diseases, insect infestation and food spoilage. The goal of the current study was to determine the lowest possible dose of gamma irradiation that will induce longterm sterility of insects through generations. The effect of four gamma irradiation doses examined were; 20,40, 50 and 70 Gy. Irradiated males were crossed with normal females. For the cowpea beetle Callosobruchus maculatus(F.), adult fecundity, hatchability, adult emergence, sterility% was investigated. 100% adult mortality was achieved by 70 Gy dose. Fecundity, hatchability, number of adults emerged, sterility% were significantly reduced when males exposed to 20, 40, and 50 Gy compared to the control. The effect of parental irradiated males exposed to 20 Gy on F2 generation was also studied. Fecundity, hatchability, number of adult emerged, sterility% were significantly reduced in F2 compared to F1 and control progeny. Interestingly, for F1 generation, the effect of gamma rays on adult emergence% exhibit a hermetic effect response although it was not significant. These results demonstrat that pulse irradiation relying on low-doses of gamma radiation induce inherited semi-sterility through generations and is a very promising phytosanitary food technology for postharvest treatments.Phytosanitary irradiation for food commodities has been widely accepted in recent years. Gamma irradiation has been used as a phytosanitary treatment against microbial diseases, insect infestation and food spoilage. The goal of the current study was to determine the lowest possible dose of gamma irradiation that will induce longterm sterility of insects through generations. The effect of four gamma irradiation doses examined were; 20,40, 50 and 70 Gy. Irradiated males were crossed with normal females. For the cowpea beetle Callosobruchus maculatus(F.), adult fecundity, hatchability, adult emergence, sterility% was investigated. 100% adult mortality was achieved by 70 Gy dose. Fecundity, hatchability, number of adults emerged, sterility% were significantly reduced when males exposed to 20, 40, and 50 Gy compared to the control. The effect of parental irradiated males exposed to 20 Gy on F2 generation was also studied. Fecundity, hatchability, number of adult emerged, sterility% were significantly reduced in F2 compared to F1 and control progeny. Interestingly, for F1 generation, the effect of gamma rays on adult emergence% exhibit a hermetic effect response although it was not significant. These results demonstrat that pulse irradiation relying on low-doses of gamma radiation induce inherited semi-sterility through generations and is a very promising phytosanitary food technology for postharvest treatments

    CONTINUOUS MONITORING OF MOVEMENT IN PATIENTS WITH PARKINSON'S DISEASE USING INERTIAL SENSORS

    Get PDF
    Gait impairment is a hallmark of Parkinson's disease (PD). The assessment of gait and balance in the clinic may not adequately reflect mobility in daily life. It is often reported that patients with PD walk better when they are examined in an outpatient clinic or in a research laboratory than at home. Continuous monitoring of mobility during spontaneous daily activities may provide clinicians and patients with objective measures of the quality of their mobility. We show that continuous monitoring of spontaneous gait with wearable inertial sensors during daily activities is feasible for patients with PD. We tested 13 patients with PD and 8 healthy controls to evaluate the feasibility of using wearable inertial sensors at home for one week. The inertial system successfully detects walking bouts and provides sixteen objective measures that can characterize gait changes in patients with PD

    Inertial and Time-of-Arrival Ranging Sensor Fusion

    Get PDF
    Wearable devices with embedded kinematic sensors including triaxial accelerometers, gyroscopes, and magnetometers are becoming widely used in applications for tracking human movement in domains that include sports, motion gaming, medicine, and wellness. The kinematic sensors can be used to estimate orientation, but can only estimate changes in position over short periods of time. We developed a prototype sensor that includes ultra wideband ranging sensors and kinematic sensors to determine the feasibility of fusing the two sensor technologies to estimate both orientation and position. We used a state space model and applied the unscented Kalman filter to fuse the sensor information. Our results demonstrate that it is possible to estimate orientation and position with less error than is possible with either sensor technology alone. In our experiment we obtained a position root mean square error of 5.2 cm and orientation error of 4.8° over a 15 min recording

    Effect of ciprofloxacin incorporation in PVA and PVA bioactive glass composite scaffolds

    No full text
    International audienceScaffolds are implants used to deliver cells, drugs, and genes into the body in a local controlled release pattern which offers many advantages over systematic drug delivery. Composite scaffolds of polyvinyl alcohol (PVA) and quaternary bioactive glass (46S6 system) with different ratios of glass contents were prepared by the lyophilisation technique. The broad spectrum antibiotic ciprofloxacin (Cip) was impregnated to the scaffold during the fabrication in a concentration of 5, 10 and 20%. Biodegradation rate and in-vitro mineralization of the prepared scaffolds were performed by soaking the scaffolds in simulated body fluid (SBF). Phase identification, microstructure, porosity, bioactivity, mechanical properties and drug release pattern in PBS were characterized by XRD, SEM coupled with EDS, Hg-porosimeter, inductively coupled plasma-optical emission spectroscopy (ICP-OES), universal testing machine, fourier transform infrared (FTIR) and UV-spectrophotometer, respectively. A porous scaffold has been obtained with porosity up to 85%. By increasing the glass contents in the prepared scaffold the porosity and the degradation rate decrease however, the compressive strength was enhanced. A sustained drug release pattern was observed with a quasi-Fickian diffusion mechanism. The formulated ciprofloxacin loaded porous polyvinyl alcohol scaffold gave an acceptable physicochemical properties and was able to deliver the drug in a prolonged release pattern which offers a distinguish treatment for osteomylitis as well as local antibacterial effect

    Investigation of Radioactivity Levels in Soil at JUST Campus Prior to the Construction of JRTR

    Get PDF
    An investigation of the background radiation level in soil samples collected from the campus of Jordan University of Science and Technology (JUST) was carried out. A random systematic approach was employed for selecting the sampling locations around the proposed site of Jordan Research and Training Reactor (JRTR). A counting system based on a High Purity Germanium (HPGe) detector coupled with GENIE 2000 spectroscopy software was used to analyze the samples. The average concentration of radionuclides 226Ra, 232Th, 40K, 137Cs and 238U were found to be 20.84, 24.45, 312.39, 2.43 and 83.88 Bq/kg, respectively. Results were compared with published data available in the literature. The measured results will form the baseline for future monitoring of radiological impact of JRTR on JUST campus

    Fall Prediction Based on Instrumented Measures of Gait and Turning in Daily Life in People with Multiple Sclerosis

    Get PDF
    This study investigates the potential of passive monitoring of gait and turning in daily life in people with multiple sclerosis (PwMS) to identify those at future risk of falls. Seven days of passive monitoring of gait and turning were carried out in a pilot study of 26 PwMS in home settings using wearable inertial sensors. The retrospective fall history was collected at the baseline. After gait and turning data collection in daily life, PwMS were followed biweekly for a year and were classified as fallers if they experienced \u3e1 fall. The ability of short-term passive monitoring of gait and turning, as well as retrospective fall history to predict future falls were compared using receiver operator curves and regression analysis. The history of retrospective falls was not identified as a significant predictor of future falls in this cohort (AUC = 0.62, p = 0.32). Among quantitative monitoring measures of gait and turning, the pitch at toe-off was the best predictor of falls (AUC = 0.86, p \u3c 0.01). Fallers had a smaller pitch of their feet at toe-off, reflecting less plantarflexion during the push-off phase of walking, which can impact forward propulsion and swing initiation and can result in poor foot clearance and an increased metabolic cost of walking. In conclusion, our cohort of PwMS showed that objective monitoring of gait and turning in daily life can identify those at future risk of falls, and the pitch at toe-off was the single most influential predictor of future falls. Therefore, interventions aimed at improving the strength of plantarflexion muscles, range of motion, and increased proprioceptive input may benefit PwMS at future fall risk

    Effect of Bout Length on Gait Measures in People with and without Parkinson’s Disease during Daily Life

    Get PDF
    Although the use of wearable technology to characterize gait disorders in daily life is increasing, there is no consensus on which specific gait bout length should be used to characterize gait. Clinical trialists using daily life gait quality as study outcomes need to understand how gait bout length affects the sensitivity and specificity of measures to discriminate pathological gait as well as the reliability of gait measures across gait bout lengths. We investigated whether Parkinson’s disease (PD) affects how gait characteristics change as bout length changes, and how gait bout length affects the reliability and discriminative ability of gait measures to identify gait impairments in people with PD compared to neurotypical Old Adults (OA). We recruited 29 people with PD and 20 neurotypical OA of similar age for this study. Subjects wore 3 inertial sensors, one on each foot and one over the lumbar spine all day, for 7 days. To investigate which gait bout lengths should be included to extract gait measures, we determined the range of gait bout lengths available across all subjects. To investigate if the effect of bout length on each gait measure is similar or not between subjects with PD and OA, we used a growth curve analysis. For reliability and discriminative ability of each gait measure as a function of gait bout length, we used the intraclass correlation coefficient (ICC) and area under the curve (AUC), respectively. Ninety percent of subjects walked with a bout length of less than 53 strides during the week, and the majority (\u3e50%) of gait bouts consisted of less than 12 strides. Although bout length affected all gait measures, the effects depended on the specific measure and sometimes differed for PD versus OA. Specifically, people with PD did not increase/decrease cadence and swing duration with bout length in the same way as OA. ICC and AUC characteristics tended to be larger for shorter than longer gait bouts. Our findings suggest that PD interferes with the scaling of cadence and swing duration with gait bout length. Whereas control subjects gradually increased cadence and decreased swing duration as bout length increased, participants with PD started with higher than normal cadence and shorter than normal stride duration for the smallest bouts, and cadence and stride duration changed little as bout length increased, so differences between PD and OA disappeared for the longer bout lengths. Gait measures extracted from shorter bouts are more common, more reliable, and more discriminative, suggesting that shorter gait bouts should be used to extract potential digital biomarkers for people with PD

    Laboratory versus daily life gait characteristics in patients with multiple sclerosis, Parkinson’s disease, and matched controls

    Get PDF
    Background and purpose Recent findings suggest that a gait assessment at a discrete moment in a clinic or laboratory setting may not reflect functional, everyday mobility. As a step towards better understanding gait during daily life in neurological populations, we compared gait measures that best discriminated people with multiple sclerosis (MS) and people with Parkinson’s Disease (PD) from their respective, age-matched, healthy control subjects (MS-Ctl, PD-Ctl) in laboratory tests versus a week of daily life monitoring. Methods We recruited 15 people with MS (age mean ± SD: 49 ± 10 years), 16 MS-Ctl (45 ± 11 years), 16 people with idiopathic PD (71 ± 5 years), and 15 PD-Ctl (69 ± 7 years). Subjects wore 3 inertial sensors (one each foot and lower back) in the laboratory followed by 7 days during daily life. Mann–Whitney U test and area under the curve (AUC) compared differences between PD and PD-Ctl, and between MS and MS-Ctl in the laboratory and in daily life. Results Participants wore sensors for 60–68 h in daily life. Measures that best discriminated gait characteristics in people with MS and PD from their respective control groups were different between the laboratory gait test and a week of daily life. Specifically, the toe-off angle best discriminated MS versus MS-Ctl in the laboratory (AUC [95% CI] = 0.80 [0.63–0.96]) whereas gait speed in daily life (AUC = 0.84 [0.69–1.00]). In contrast, the lumbar coronal range of motion best discriminated PD versus PD-Ctl in the laboratory (AUC = 0.78 [0.59–0.96]) whereas foot-strike angle in daily life (AUC = 0.84 [0.70–0.98]). AUCs were larger in daily life compared to the laboratory. Conclusions Larger AUC for daily life gait measures compared to the laboratory gait measures suggest that daily life monitoring may be more sensitive to impairments from neurological disease, but each neurological disease may require different gait outcome measures

    Feasibility of a Novel Therapist-Assisted Feedback System for Gait Training in Parkinson’s Disease

    Get PDF
    We tested the feasibility of one session of treadmill training using a novel physical therapist assisted system (Mobility Rehab) using wearable sensors on the upper and lower limbs of 10 people with Parkinson’s disease (PD). Participants performed a 2-min walk overground before and after 15 min of treadmill training with Mobility Rehab, which included an electronic tablet (to visualize gait metrics) and five Opal sensors placed on both the wrists and feet and on the sternum area to measure gait and provide feedback on six gait metrics (foot-strike angle, trunk coronal range-of-motion (ROM), arm swing ROM, double-support duration, gait-cycle duration, and step asymmetry). The physical therapist used Mobility Rehab to select one or two gait metrics (from the six) to focus on during the treadmill training. Foot-strike angle (effect size (ES) = 0.56, 95% Confidence Interval (CI) = 0.14 to 0.97), trunk coronal RoM (ES = 1.39, 95% CI = 0.73 to 2.06), and arm swing RoM (ES = 1.64, 95% CI = 0.71 to 2.58) during overground walking showed significant and moderate-to-large ES following treadmill training with Mobility Rehab. Participants perceived moderate (60%) and excellent (30%) effects of Mobility Rehab on their gait. No adverse events were reported. One session of treadmill training with Mobility Rehab is feasible for people with mild-to-moderate PD

    Effectiveness of the Mobility Rehab System for Mobility Training in Older Adults: A Pragmatic Clinical Trial

    Get PDF
    Introduction: Mobility impairments are among the main causes of falls in older adults and patients with neurological diseases, leading to functional dependence and substantial health care costs. Feedback-based interventions applied in controlled, laboratory environments have shown promising results for mobility rehabilitation, enhancing the benefits of standard therapy. However, the effectiveness of sensor-based feedback to improve gait in actual outpatient physical therapy settings is unknown. The proposed trial examines the effectiveness of a physical therapist-assisted, visual feedback system using wearable inertial sensors, Mobility Rehab, for mobility training in older adults with gait disturbances in an outpatient clinic. Methods: The study is a single site, pragmatic clinical trial in older adults with gait disturbances. Two hundred patients undergoing their outpatient rehabilitation program are assigned, by an independent assistant, for screening by one of four therapists, and assigned to either a standard physical therapy or therapist-assisted feedback therapy. Both groups train twice a week for 6 weeks. Four physical therapists were randomized and stratified by years of experience to deliver standard therapy or therapist-assisted feedback rehabilitation. Each session is 45 min long. Gait is trained for 30 min. The additional 15 min include exercises for endurance, strength, and static and dynamic balance in functional tasks. Mobility Rehab uses unobtrusive, inertial sensors on the feet and belt with real-time algorithms to provide real-time feedback on gait metrics (i.e., gait speed, double support time, foot clearance, angle at foot strike, and arm swing), which are displayed on a hand-held monitor. Blinded assessments are carried out before and after the intervention. The primary outcome measure is subjects' perception of balance as measured by the Activities-specific Balance Confidence scale. Gait speed, as measured with wearable inertial sensors during walking, is the secondary outcome measure. Discussion: We hypothesize that therapist-assisted feedback rehabilitation will be more effective than standard rehabilitation for gait. Feedback of motor performance plays a crucial role in rehabilitation and objective characterization of gait impairments by Mobility Rehab has the potential to improve the accuracy of patient-specific gait feedback. Clinical Trial Registration: www.ClinicalTrials.gov, identifier: NCT03869879
    • …
    corecore